Literature DB >> 124700

HL-A frequencies in Down's syndrome.

D J Segal, J W Schlaut, H F Pabst, E E McCoy, J B Dossetor.   

Abstract

HL-A antigen frequencies were examined in 76 Down's syndrome individuals and 733 normal Caucasians. 10 antigens of the first locus and 15 antigens of the second locus were defined, using a microlymphocytotoxicity technique. No significant differences were observed between the normal and Down's syndrome samples, in contrast to a previous report (Boxer and Yokoyama, 1972) of decreased HL-A antigen frequencies in Down's syndrome individuals. Our results therefore suggest that there is no relationship between trisomy 21-associated immune aberrations and altered HL-A antigen frequencies.

Mesh:

Substances:

Year:  1975        PMID: 124700     DOI: 10.1007/bf00283502

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


  12 in total

1.  A formal genetic analysis of the HL-A system.

Authors:  A Piazza; N E Morton
Journal:  Am J Hum Genet       Date:  1973-03       Impact factor: 11.025

2.  Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group.

Authors:  R T Oliver; J A Sachs; H Festenstein; G D Pegrum; J F Moorhead
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

3.  Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature.

Authors:  F Rosner; S L Lee
Journal:  Am J Med       Date:  1972-08       Impact factor: 4.965

4.  Familial predisposition to thyroid disease in Down's syndrome: controlled immunoclinical studies.

Authors:  P J Fialkow; H C Thuline; F Hecht; J Bryant
Journal:  Am J Hum Genet       Date:  1971-01       Impact factor: 11.025

5.  HL-A-linked human immune-response genes.

Authors:  C E Buckley; F C Dorsey; R B Corley; W B Ralph; M A Woodbury; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

6.  Association of the HL-A7 cross-reacting group with a specific reaginic antibody response in allergic man.

Authors:  D G Marsh; W B Bias; S H Hsu; L Goodfriend
Journal:  Science       Date:  1973-02-16       Impact factor: 47.728

7.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

8.  HL-A antigens and diseases. I. Multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog; T Ammitzboll
Journal:  Tissue Antigens       Date:  1973

9.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

10.  A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems.

Authors:  N Yasuda; M Kimura
Journal:  Ann Hum Genet       Date:  1968-05       Impact factor: 1.670

View more
  3 in total

1.  HLA in Graves' disease coexistent with coeliac disease.

Authors:  R Lorini; D Larizza; M S Scotta; F Severi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

2.  HLA and peptic ulcer.

Authors:  B D O'Brien; A B Thomson; J B Dossetor
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

3.  Decreased HLA heterogeneity in parents of children with Down syndrome.

Authors:  V D Mottironi; E B Hook; A M Willey; I H Porter; R V Swift; N H Hatcher
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.